v3.26.1
SCHEDULE OF SEGMENT INFORMATION (Details) - USD ($)
 3 Months Ended 12 Months Ended
Sep. 23, 2025
Aug. 01, 2025
Apr. 22, 2025
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting Information [Line Items]                  
Revenues, net         $ 15,768,796 $ 22,853   $ 10,297,778 $ 1,930,291
Cost of revenue         (15,681,380) (7,374)   (10,171,937) (1,898,122)
Gross profit         87,416 15,479   125,841 32,169
Operating expenses         (2,079,989) (1,517,758)   (4,419,331) (6,425,572)
Loss from operations         (1,992,573) (1,502,279)   (5,198,364) (10,863,015)
Fair value variation         (17,502,596) $ (17,502,596) 2,024,465 (82,844)
Other income         76,102 9,047   474,954 532,593
Other expense         (7,206) (43,017)   (309,121) (665,795)
Net loss from continuing operations         (19,426,273) (1,536,249)   (4,887,460) (12,178,813)
Operating expenses               (4,419,331)  
Allowance for credit loss               (2,098) (3,450,141)
Inventory write-down               (902,776)  
Loss on acquisition $ (113) $ (1,859,071) $ (45) $ (20,164)       (20,210)
Goodwill impairment               (1,859,184)
Other income               474,954  
Impairment loss on assets held for sale               203,973
Loss from investment           (1,092,169)
Interest expense, net           (7,583)
Gain from discontinued operations [1]               3,206,078
Net loss         (19,426,273) $ (1,536,249)   (4,890,555) (8,972,735)
Operating Segments [Member]                  
Segment Reporting Information [Line Items]                  
Revenues, net         15,768,796     10,298,669  
Cost of revenue         (15,681,380)     (10,172,828)  
Gross profit         87,416     125,841  
Operating expenses         (2,079,989)        
Loss from operations         (1,992,573)     (5,198,364)  
Fair value variation         (17,502,596)     2,024,465  
Other income         76,102        
Other expense         (7,206)     (309,121)  
Net loss from continuing operations         (19,426,273)     (4,887,460)  
Operating expenses               (4,419,331)  
Allowance for credit loss               (2,098)  
Inventory write-down               (902,776)  
Loss on acquisition               (20,210)  
Goodwill impairment               (1,859,184)  
Other income               474,954  
Homology of Medicine and Food Series [Member] | Operating Segments [Member]                  
Segment Reporting Information [Line Items]                  
Revenues, net         1,426,832     6,349,252  
Cost of revenue         (1,408,815)     (6,278,927)  
Gross profit         18,017     70,325  
Operating expenses         (155,181)        
Loss from operations         (137,164)     48,213  
Fair value variation              
Other income         74,271        
Other expense         (7,107)     (143)  
Net loss from continuing operations         (70,000)     1,831,211  
Operating expenses               (20,014)  
Allowance for credit loss               (2,098)  
Inventory write-down                
Loss on acquisition               (20,210)  
Goodwill impairment               (1,859,071)  
Other income                
Computing Power Product Series [Member] | Operating Segments [Member]                  
Segment Reporting Information [Line Items]                  
Revenues, net         2,360,373     3,804,691  
Cost of revenue         (2,290,396)     (3,777,292)  
Gross profit         69,977     27,399  
Operating expenses         (33,049)        
Loss from operations         36,928     (33,587)  
Fair value variation              
Other income         177        
Other expense         (9)     (71)  
Net loss from continuing operations         37,096     (33,658)  
Operating expenses               (60,986)  
Allowance for credit loss                
Inventory write-down                
Loss on acquisition                
Goodwill impairment                
Other income                
Maca Product [Member] | Operating Segments [Member]                  
Segment Reporting Information [Line Items]                  
Revenues, net         11,981,591     144,726  
Cost of revenue         (11,982,169)     (116,609)  
Gross profit         (578)     28,117  
Operating expenses         (270,238)        
Loss from operations         (270,816)     (2,481,470)  
Fair value variation              
Other income         1,654        
Other expense         (90)     (9,125)  
Net loss from continuing operations         (269,252)     (2,420,360)  
Operating expenses               (1,606,811)  
Allowance for credit loss                
Inventory write-down               (902,776)  
Loss on acquisition                
Goodwill impairment                
Other income               70,235  
Others Unallocated Headquarter Costs [Member] | Operating Segments [Member]                  
Segment Reporting Information [Line Items]                  
Revenues, net                
Cost of revenue                
Gross profit                
Operating expenses         (1,621,521)        
Loss from operations         (1,621,521)        
Fair value variation         (17,502,596)        
Other income                
Other expense                
Net loss from continuing operations         $ (19,124,117)        
Others Headquarter [Member] | Operating Segments [Member]                  
Segment Reporting Information [Line Items]                  
Revenues, net                
Cost of revenue                
Gross profit                
Loss from operations               (2,731,520)  
Fair value variation               2,024,465  
Other expense               (299,782)  
Net loss from continuing operations               (602,231)  
Operating expenses               (2,731,520)  
Allowance for credit loss                
Inventory write-down                
Loss on acquisition                
Goodwill impairment               (113)  
Other income               404,719  
Adjustments And Eliminations [Member] | Operating Segments [Member]                  
Segment Reporting Information [Line Items]                  
Revenues, net               (891)  
Cost of revenue               891  
Gross profit                
Loss from operations                
Fair value variation                
Other expense                
Net loss from continuing operations                
Operating expenses                
Allowance for credit loss                
Inventory write-down                
Loss on acquisition                
Goodwill impairment                
Other income                
Maca Product Series [Member]                  
Segment Reporting Information [Line Items]                  
Revenues, net                 1,930,291
Cost of revenue                 (1,898,122)
Gross profit                 32,169
Loss from operations                 (10,863,015)
Other expense                 (665,795)
Operating expenses                 (6,425,572)
Allowance for credit loss                 (3,450,141)
Inventory write-down                 815,498
Other income                 532,593
Impairment loss on assets held for sale                 (203,973)
Fair value variation                 (82,844)
Loss from investment                 (1,092,169)
Interest expense, net                 (7,583)
Gain from discontinued operations                 3,206,078
Net loss                 $ (8,972,735)
[1] On June 7, 2024, the Company sold (i) NuZee Korea Ltd., a company incorporated in Korea, and (ii) NuZee Investment Co., Ltd., a company incorporated in Japan, each of which was a wholly owned subsidiary of the Company.